focus -WSS

focus

author：explore 2025-10-01 00:49:44 - browse：14612

Bernard Moss, a research scientist at NIAID. -- Infectious disease coverage from STAT — Bernard Moss Courtesy NIAID

For more than half a century, scientist Bernard Moss has been commanding the attention of peers interested in prying biological secrets from poxviruses and other microbiological targets. Now he’s commanding the attention of a different audience: House Republicans.

Moss, who will mark his 86th birthday in late July and who goes by Bernie, has worked for more than 55 years in the laboratories of the National Institute of Allergy and Infectious Diseases in Bethesda, Md. Over that time, he has been investigating viruses in relative anonymity — except, that is, among the virological cognoscenti.

But last year, in an interview with Science, Moss said he planned to try to determine why one strain of mpox viruses, known as Clade 1, is so much more virulent than those in a second strain, Clade 2, by taking genes from the former and putting them into the latter. Clade 2 viruses are responsible for the ongoing mpox outbreak first detected in May 2022.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Alkermes shareholders re
Next article： 'Ancient DNA,' 23andMe reveal African American ancestries

explore

WSS

A cyberattack has disrupted hospitals and health care in several states

Can U.S. cancer drug shortages be fixed?

Dramatically reducing cancer deaths requires the PASTEUR Act

Trump drops motion seeking removal of DA probing efforts to overturn 2020 election in Georgia

What the cancer research community can learn from the Covid response

Health officials lay out plans to cope with respiratory virus season

Wikipedia

focus

focus

DIEP, the 'gold standard' of breast reconstruction, is under threat

For BCIs, commercial hurdles may be bigger than scientific ones

State Dept. review finds Biden bears some blame for Afghanistan failures

Attacks on the drug industry will lead to fewer breakthroughs

Anesthesiologist group: stop taking Ozempic before surgery

Roche's accidental data boosts hopes for anti

Hepatitis C has a cure — but many Americans still lack access to it

What Henrietta Lacks settlement says about racism in medicine

At least 13 dead in Texas as scorching temps continue

For BCIs, commercial hurdles may be bigger than scientific ones

explore

White House drug shortage group privately met with industry

PBMs are inflating the cost of generic drugs. They must be reined in

FDA advisory panel to debate high blood pressure devices

What past blockbusters can tell us about future of Wegovy and other weight loss medicines

Biden calls for immediate release of Niger's president amid apparent coup

Meadows told special counsel he could not recall Trump ever declassifying Mar

explore

focus

explore

explore